AU6325799A - New compounds, their preparation and use - Google Patents
New compounds, their preparation and useInfo
- Publication number
- AU6325799A AU6325799A AU63257/99A AU6325799A AU6325799A AU 6325799 A AU6325799 A AU 6325799A AU 63257/99 A AU63257/99 A AU 63257/99A AU 6325799 A AU6325799 A AU 6325799A AU 6325799 A AU6325799 A AU 6325799A
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- new compounds
- compounds
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA | 1998-10-14 | ||
DKPA199801354 | 1998-10-21 | ||
PCT/DK1999/000573 WO2000023451A1 (en) | 1998-10-21 | 1999-10-19 | New compounds, their preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6325799A true AU6325799A (en) | 2000-05-08 |
Family
ID=8103937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU63257/99A Abandoned AU6325799A (en) | 1998-10-21 | 1999-10-19 | New compounds, their preparation and use |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1123297A1 (en) |
JP (1) | JP2002527520A (en) |
AU (1) | AU6325799A (en) |
WO (1) | WO2000023451A1 (en) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2192000A (en) * | 1998-12-17 | 2000-07-03 | Mindset Biopharmaceuticals (Usa) Inc. | Increasing brain glucose utilization |
WO2000063209A1 (en) | 1999-04-20 | 2000-10-26 | Novo Nordisk A/S | New compounds, their preparation and use |
WO2001053257A2 (en) * | 2000-01-19 | 2001-07-26 | Cadila Healthcare Ltd. | Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them |
WO2001066135A1 (en) | 2000-03-08 | 2001-09-13 | Novo Nordisk A/S | Lowering serum lipids |
EP1911462A3 (en) | 2001-01-26 | 2011-11-30 | Schering Corporation | Compositions comprising a sterol absorption inhibitor |
US6987123B2 (en) * | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
JP4563675B2 (en) | 2001-10-12 | 2010-10-13 | ハイ・ポイント・ファーマスーティカルズ、エルエルシー | Substituted piperidines and their use for the treatment of histamine H3 receptor related diseases |
CZ2004747A3 (en) | 2001-12-21 | 2004-11-10 | Novo Nordisk A/S | Amide derivatives functioning as GK activators |
US7015345B2 (en) | 2002-02-21 | 2006-03-21 | Asahi Kasei Pharma Corporation | Propionic acid derivatives |
MXPA05000130A (en) | 2002-06-27 | 2005-02-17 | Novo Nordisk As | Aryl carbonyl derivatives as therapeutic agents. |
US7268157B2 (en) * | 2002-11-26 | 2007-09-11 | Shenzhen Chipscreen Biosciences, Ltd. | Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
AU2004229440B2 (en) | 2003-04-10 | 2010-08-12 | President And Fellows Of Harvard College | Formation and control of fluidic species |
JP2007503453A (en) | 2003-05-14 | 2007-02-22 | ノボ ノルディスク アクティーゼルスカブ | Novel compounds for treating obesity |
CN100482682C (en) | 2003-09-30 | 2009-04-29 | 诺沃挪第克公司 | Novel melanocortin receptor agonists |
JP4865565B2 (en) | 2003-12-09 | 2012-02-01 | ノヴォ ノルディスク アー/エス | Controlling food selection using GLP-1 agonists |
WO2005066145A1 (en) | 2004-01-06 | 2005-07-21 | Novo Nordisk A/S | Heteroaryl-ureas and their use as glucokinase activators |
EP1758856A2 (en) | 2004-05-04 | 2007-03-07 | Novo Nordisk A/S | Indole derivatives for the treatment of obesity |
WO2005120492A1 (en) | 2004-06-11 | 2005-12-22 | Novo Nordisk A/S | Counteracting drug-induced obesity using glp-1 agonists |
JP4874989B2 (en) | 2004-11-22 | 2012-02-15 | ノヴォ ノルディスク アー/エス | Soluble and stable insulin-containing formulation |
MX2007006420A (en) | 2004-12-03 | 2007-07-19 | Novo Nordisk As | Heteroaromatic glucokinase activators. |
EP2233470B1 (en) | 2005-07-04 | 2011-12-07 | High Point Pharmaceuticals, LLC | Histamine H3 receptor antagonists |
ES2422383T3 (en) | 2005-07-14 | 2013-09-11 | Novo Nordisk As | Urea glucokinase activators |
EP1910317B1 (en) | 2005-07-20 | 2013-07-03 | Eli Lilly And Company | 1-amino linked compounds |
WO2007123581A1 (en) | 2005-11-17 | 2007-11-01 | Eli Lilly And Company | Glucagon receptor antagonists, preparation and therapeutic uses |
EP1999120B1 (en) | 2006-03-28 | 2012-06-27 | High Point Pharmaceuticals, LLC | Benzothiazoles having histamine h3 receptor activity |
ES2375872T3 (en) | 2006-05-29 | 2012-03-07 | High Point Pharmaceuticals, Llc | 3- (1,3-BENZODIOXOL-5-IL) -6- (4-CYCLOPROPYLPIPERACIN-1-IL) -PIRIDACINE, ITS SALTS AND SOLVATES, AND ITS USE AS AN HISTAMINE RECEIVER ANTAGONIST. |
WO2008059026A1 (en) | 2006-11-15 | 2008-05-22 | High Point Pharmaceuticals, Llc | Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes |
US8022066B2 (en) | 2006-11-15 | 2011-09-20 | High Point Pharmaceuticals, Llc | 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes |
EP2099777B1 (en) | 2007-01-11 | 2015-08-12 | Novo Nordisk A/S | Urea glucokinase activators |
EP2464645B1 (en) | 2009-07-27 | 2017-07-05 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
US20130012432A1 (en) | 2010-02-26 | 2013-01-10 | Novo Nordisk A/S | Peptides for Treatment of Obesity |
BR112012021231A2 (en) | 2010-02-26 | 2015-09-08 | Basf Plant Science Co Gmbh | method for enhancing plant yield, plant, construct, use of a construct, method for producing a transgenic plant, collectable parts of a plant, products derived from a plant, use of a nucleic acid and method for producing a product |
US20130143798A1 (en) | 2010-03-26 | 2013-06-06 | Novo Nordisk A/S | Novel glucagon analogues |
MX2012015096A (en) | 2010-07-02 | 2013-05-28 | Gilead Sciences Inc | Fused heterocyclic compounds as ion channel modulators. |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
AP3920A (en) | 2011-01-31 | 2016-12-02 | Cadila Healthcare Ltd | Treatment for lipodystrophy |
EP2670368A4 (en) | 2011-02-03 | 2015-04-15 | Pharmedica Ltd | New oral dissolving films for insulin administration, for treating diabetes |
WO2012130866A1 (en) | 2011-03-28 | 2012-10-04 | Novo Nordisk A/S | Novel glucagon analogues |
NZ716420A (en) | 2011-05-10 | 2017-05-26 | Gilead Sciences Inc | Fused heterocyclic compounds as sodium channel modulators |
UY34171A (en) | 2011-07-01 | 2013-01-31 | Gilead Sciences Inc | FUSIONED HETEROCYCLIC COMPOUNDS AS IONIC CHANNEL MODULATORS |
NO3175985T3 (en) | 2011-07-01 | 2018-04-28 | ||
JP6352806B2 (en) | 2011-09-23 | 2018-07-04 | ノヴォ ノルディスク アー/エス | New glucagon analogues |
BR112015025464A2 (en) | 2013-04-18 | 2017-10-10 | Novo Nordisk As | stable, prolonged glp-1 / glucagon receptor coagonists for medical use |
MA38385A1 (en) | 2013-04-22 | 2017-09-29 | Cadila Healthcare Ltd | New composition for non-alcoholic fatty liver disease (nafld) |
US20160107989A1 (en) | 2013-05-30 | 2016-04-21 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
TW201636015A (en) | 2013-07-05 | 2016-10-16 | 卡地拉保健有限公司 | Synergistic compositions |
IN2013MU02470A (en) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
US10570184B2 (en) | 2014-06-04 | 2020-02-25 | Novo Nordisk A/S | GLP-1/glucagon receptor co-agonists for medical use |
AU2015360416A1 (en) | 2014-12-10 | 2017-06-08 | Massachusetts Institute Of Technology | Fused 1,3-azole derivatives useful for the treatment of proliferative diseases |
WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
RU2018132559A (en) | 2016-02-16 | 2020-03-17 | Массачусетс Инститьют Оф Текнолоджи | BINDING MOLECULES FOR MAX AS MYC MODULATORS AND THEIR APPLICATIONS |
EP3551180B1 (en) | 2016-12-09 | 2021-09-29 | Cadila Healthcare Limited | Treatment for primary biliary cholangitis |
US20200223889A1 (en) | 2017-03-15 | 2020-07-16 | Novo Nordisk A/S | Bicyclic Compounds Capable of Binding to Melanocortin 4 Receptor |
CN111356695B (en) * | 2017-10-27 | 2022-12-30 | 北京加科思新药研发有限公司 | Novel tricyclic compounds |
WO2019219714A1 (en) | 2018-05-15 | 2019-11-21 | Novo Nordisk A/S | Compounds capable of binding to melanocortin 4 receptor |
WO2020053414A1 (en) | 2018-09-14 | 2020-03-19 | Novo Nordisk A/S | Bicyclic compounds capable of acting as melanocortin 4 receptor agonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9508468A (en) * | 1994-07-29 | 1997-11-25 | Smithkline Beecham Plc | Compound process for the preparation of the same pharmaceutical composition processes for the treatment and / or prophylaxis of hyperglycemia in a human or non-human mammal and for the treatment of hyperlipidemia hypertension cardiovascular disease some eating disorders the treatment and / or prophylaxis of kidney disease prevention revers o stabilization or retardation of microalbuminuria progression in a human or non-human mammal use of the compound and intermediate compound |
GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
WO1999019313A1 (en) * | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
-
1999
- 1999-10-19 JP JP2000577177A patent/JP2002527520A/en active Pending
- 1999-10-19 WO PCT/DK1999/000573 patent/WO2000023451A1/en not_active Application Discontinuation
- 1999-10-19 EP EP99950503A patent/EP1123297A1/en not_active Withdrawn
- 1999-10-19 AU AU63257/99A patent/AU6325799A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002527520A (en) | 2002-08-27 |
EP1123297A1 (en) | 2001-08-16 |
WO2000023451A1 (en) | 2000-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6325599A (en) | New compounds, their preparation and use | |
AU6325899A (en) | New compounds, their preparation and use | |
AU6190199A (en) | New compounds, their preparation and use | |
AU6325799A (en) | New compounds, their preparation and use | |
AU6190299A (en) | New compounds, their preparation and use | |
AU6325699A (en) | New compounds, their preparation and use | |
AU3958100A (en) | New compounds, their preparation and use | |
AU3958200A (en) | New compounds, their preparation and use | |
AU3957900A (en) | New compounds, their preparation and use | |
PL351312A1 (en) | New compounds, their preparation and use | |
HK1078561A1 (en) | Novel compounds, their use and preparation | |
AU2001248279A1 (en) | New compounds, their preparation and use | |
PL347371A1 (en) | Substituted phenyl derivatives, their preparation and use | |
PL351250A1 (en) | Antipicornaviral compounds, their preparation and use | |
EP1072266B8 (en) | Thienylazolylalcoxyethanamines, their preparation and their application as medicaments | |
AU5638999A (en) | Dispersants, compositions and use | |
AU5970699A (en) | Use | |
AU3595099A (en) | New compounds, their preparation and use | |
AUPP584198A0 (en) | New use | |
AU5176299A (en) | Compound, composition and use | |
AU1046799A (en) | Compound, composition and use | |
AU6235799A (en) | New use | |
AU3700899A (en) | New compounds, their preparation and use | |
AU1046399A (en) | Compound, composition and use | |
AU1046499A (en) | Compound, composition and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |